Parish C L, Stanic D, Drago J, Borrelli E, Finkelstein D I, Horne M K
Neurosciences Group, Department of Medicine, Monash University, Monash Medical Centre, 246 Clayton Road, Clayton 3168, Australia.
Eur J Neurosci. 2002 Sep;16(5):787-94. doi: 10.1046/j.1460-9568.2002.02132.x.
This study demonstrates that pharmacological manipulation of the dopamine (DA) receptors can modulate the size of the axonal tree of substantia nigra pars compacta (SNpc) neurons in mice. Pharmacological blockade or genetic ablation of the D2 receptor (D2R) resulted in sprouting of DA SNpc neurons whereas treatment with a D2 agonist resulted in pruning of the terminal arbor of these neurons. Agents such as cocaine, that indirectly stimulate D2R, also resulted in reduced terminal arbor. Specific D1 agonists or antagonists had no effect on the density of DA terminals in the striatum. We conclude that the D2 receptor has a central role in regulating the size of the terminal arbor of nigrostriatal neurons. These findings have implications relating to the use of dopaminergic agonists in the management of Parkinson's disease and in controlling plasticity following injury, loss or transplantation of DA neurons.
本研究表明,对多巴胺(DA)受体进行药理学操作可调节小鼠黑质致密部(SNpc)神经元轴突树的大小。D2受体(D2R)的药理学阻断或基因敲除导致DA SNpc神经元发芽,而用D2激动剂治疗则导致这些神经元终末树突的修剪。间接刺激D2R的药物,如可卡因,也导致终末树突减少。特异性D1激动剂或拮抗剂对纹状体中DA终末的密度没有影响。我们得出结论,D2受体在调节黑质纹状体神经元终末树突的大小中起核心作用。这些发现对于多巴胺能激动剂在帕金森病管理以及控制DA神经元损伤、丢失或移植后的可塑性方面的应用具有重要意义。